ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 469 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 469 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 469 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 469 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -96.9% | 469 | -97.5% | 0.00% | – |
Q2 2022 | $32,000 | -56.2% | 18,878 | -46.8% | 0.00% | – |
Q1 2022 | $73,000 | -20.7% | 35,516 | +44.9% | 0.00% | -100.0% |
Q4 2021 | $92,000 | +15.0% | 24,515 | +59.4% | 0.00% | 0.0% |
Q3 2021 | $80,000 | +7900.0% | 15,382 | +5908.6% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 256 | -20.7% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 323 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |